Log in
Enquire now
‌

US Patent 10878703 Method of treatment of leukemia with anti-IL1RAP antibodies

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Cantargia
0
Current Assignee
‌
Cantargia
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
108787030
Date of Patent
December 29, 2020
0
Patent Application Number
159848880
Date Filed
May 21, 2018
0
Patent Citations
‌
US Patent 10287357 Methods of treating cancer using anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies
‌
US Patent 10005841 Method of treating a solid tumor with IL1RAP antibodies
‌
US Patent 10100119 Anti-human interleukin-1 receptor accessory protein antibody and its use for treating cancer
‌
US Patent 10562971 Method of detection of IL1RAP on cells expressing the protein
Patent Citations Received
‌
US Patent 11248054 Anti-IL1RAP antibodies and antibody drug conjugates
Patent Primary Examiner
‌
Elly-Gerald Stoica
0
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10878703 Method of treatment of leukemia with anti-IL1RAP antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.